Ascentage Pharma Group International
OTC: ASPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dajun Yang
- Employees
- 567
- Headquarters
- Suzhou, China
- IPO year
- 2021
- Market cap
- $1.7B
- Website
- https://www.ascentagepharma.com
Loading ASPHF…
Loading profile data…Frequently asked questions about ASPHF
What does Ascentage Pharma Group International (ASPHF) do?
Ascentage Pharma Group International (ASPHF) is a clinical-stage biotechnology firm that develops novel therapeutic agents. Its primary focus areas include oncological conditions, chronic hepatitis B (HBV), and age-related diseases, with operations concentrated in the United States and Mainland China. A cornerstone of its pipeline is HQP1351, a...
Where does ASPHF trade?
Ascentage Pharma Group International (ASPHF) trades on the Other OTC.
What sector is ASPHF in?
Ascentage Pharma Group International (ASPHF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ascentage Pharma Group International?
Dajun Yang is the chief executive officer of Ascentage Pharma Group International (ASPHF).
Where is Ascentage Pharma Group International headquartered?
Ascentage Pharma Group International is headquartered in China.
Does ASPHF pay a dividend?
Ascentage Pharma Group International (ASPHF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ASPHF go public?
Ascentage Pharma Group International (ASPHF) completed its initial public offering in 2021.